Roche first-half sales fall on strong Swiss franc

Swiss drugmaker Roche said on Thursday that its first-half sales fell in Swiss franc terms, dragged down by a strong domestic currency.

‘Rare Disease Day’ marked: Roche Pakistan holds panel discussion to raise awareness

Group sales came in at 30.36 billion Swiss francs ($37.34 billion), in line with average analyst expectations of about 30.31 billion francs cited by Visible Alpha.